EnginZyme 🇸🇪
Cell-free enzymatic biomanufacturing using immobilised enzymes for sustainable chemicals and ingredients. Solna, Sweden.
About EnginZyme
EnginZyme specializes in biomanufacturing through enzymatic catalysis, offering solutions that enhance industrial chemical processes while reducing environmental impact. Their patented enzyme immobilization technology enables the creation of stable biocatalysts for multi-step reactions, facilitating the production of various chemicals, food ingredients, and pharmaceutical components in a more sustainable manner.
EnginZyme is a Sweden-based company founded in 2014, now around 29 people. FundFinder classes it as Climate & Energy.
Founded by Robin Chatterjee (Co-founder; previously Bio-Rad Laboratories, Medivir AB; KTH Royal Institute of Technology), Karim Engelmark Cassimjee (CIO and co-founder; previously Center for Cyber Defense and Information Security, Ericsson; KTH Royal Institute of Technology), Samuel Härgestam (Co-founder; repeat founder; previously Animasher, Instabridge; Stockholm University).
Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.
Series B · Sep 2026
- Almi Invest — Almi Invest is the state-owned Swedish venture investor within the Almi Group and calls itself Sweden's most active startup investor. · cheques £75k – £300k
- Industrifonden — Evergreen Swedish venture capital fund founded in 1979 and based in Stockholm. · cheques £750k – £3.8M